Table 2.

Five-year incidence rates (2009–2013) for men and women by age

<55 ya55–64 y65–74 y75+ y
nRatenRateRR (95% CI)nRateRR (95% CI)nRateRR (95% CI)
Men
 Esophagus
  Adenocarcinoma6440.81,34811.414.9 (13.5–16.4)1,38121.628.2 (25.7–31.0)1,28827.836.3 (33.0–40.0)
  Squamous cell2180.35254.417.7 (15.1–20.9)5458.534.1 (29.0–40.1)51511.144.5 (37.9–52.4)
  Other320.0850.719.0 (12.5–29.6)951.539.2 (25.9–60.7)962.154.3 (35.9–83.9)
 Kidney and renal pelvis
  Kidney, NOS5,1446.35,50346.67.4 (7.1–7.7)5,14880.012.8 (12.3–13.3)3,83883.213.3 (12.7–13.8)
  Renal pelvis800.12141.819.3 (14.8–25.2)3255.154.3 (42.3–70.4)47210.1107.6 (84.6–138.3)
 Lung
  Squamous8190.92,72223.024.4 (22.5–26.4)4,53272.176.5 (70.9–82.5)5,006108.4114.9 (106.6–123.9)
  Small cell5790.71,57713.319.9 (18.1–22.0)2,23635.052.4 (47.7–57.5)1,80139.158.5 (53.2–64.3)
  Adenocarcinoma2,2052.65,26744.517.3 (16.4–18.1)7,247114.344.3 (42.2–46.5)7,571163.963.5 (60.5–66.6)
  Large cell1040.12382.016.6 (13.1–21.1)3104.839.9 (31.8–50.4)2776.049.7 (39.5–62.9)
  Malignant neoplasm and carcinoma unspecified6080.71,51812.818.1 (16.4–19.9)2,00931.644.5 (40.6–48.8)2,38151.272.0 (65.8–78.9)
 Thyroid
  Papillary3,3524.21,41512.02.9 (2.7–3.1)98615.33.7 (3.4–3.9)47910.42.5 (2.3–2.8)
  Follicular2460.31261.13.5 (2.8–4.4)1121.85.8 (4.6–7.3)811.85.9 (4.5–7.6)
  Medullary970.1340.32.4 (1.6–3.6)280.43.6 (2.3–5.6)210.53.8 (2.3–6.2)
  Anaplastic150.0200.210.0 (4.8–21.1)330.529.8 (15.6–59.2)310.739.5 (20.5–78.7)
Women
 Breast
  HR+/HER2+4,7905.92,90222.93.9 (3.7–4.1)1,91125.44.3 (4.1–4.6)1,45921.03.6 (3.4–3.8)
  HR/HER2+1,9852.41,39911.14.6 (4.3–4.9)82811.04.6 (4.2–5.0)6539.53.9 (3.6–4.3)
  HR+/HER224,06629.120,796163.55.6 (5.5–5.7)19,592262.69.0 (8.9–9.2)16,501240.38.3 (8.1–8.4)
  Triple-negative4,8405.93,20125.24.3 (4.1–4.4)2,27430.45.1 (4.9–5.4)1,92327.64.7 (4.4–4.9)
 Esophagus
  Adenocarcinoma1020.11811.412.0 (9.3–15.5)1872.621.6 (16.8–27.8)3184.336.3 (28.8–45.9)
  Squamous cell1160.12391.914.4 (11.5–18.2)3214.433.7 (27.1–42.1)3905.542.2 (34.1–52.5)
  Other100.0150.110.3 (4.3–25.7)240.330.1 (13.7–70.6)620.976.5 (38.4–168.0)
 Kidney and renal pelvis
  Kidney, NOS2,8533.52,68221.16.1 (5.8–6.4)2,68136.210.5 (9.9–11.1)2,69738.911.3 (10.7–11.9)
  Renal pelvis480.1970.813.6 (9.5–19.7)2183.053.3 (38.7–74.6)4596.4113.9 (84.1–157.2)
 Lung
  Squamous4280.51,28310.020.8 (18.6–23.2)2,78138.078.7 (71.0–87.3)3,43551.3106.1 (95.8–117.7)
  Small cell6260.71,47211.516.3 (14.9–18.0)2,10728.540.4 (36.9–44.3)1,88428.640.4 (36.9–44.4)
  Adenocarcinoma2,8513.35,44042.713.0 (12.4–13.6)7,787106.032.3 (30.9–33.7)8,759128.939.3 (37.6–41.0)
  Large cell880.11901.514.8 (11.4–19.3)2273.130.2 (23.4–39.1)2443.736.4 (28.3–47.1)
  Malignant neoplasm and carcinoma unspecified5680.61,0308.112.4 (11.2–13.8)1,49920.531.6 (28.7–34.9)2,03929.545.4 (41.3–50.0)
 Thyroid
  Papillary13,58616.93,91030.91.8 (1.8–1.9)2,24429.61.8 (1.7–1.8)1,00715.50.9 (0.9–1.0)
  Follicular7781.02602.12.1 (1.9–2.5)2263.13.2 (2.7–3.7)1472.32.4 (2.0–2.8)
  Medullary1320.2720.63.5 (2.6–4.7)570.84.8 (3.4–6.6)310.52.9 (1.8–4.3)
  Anaplastic90.0280.221.3 (9.7–51.6)450.661.7 (29.4–144.3)851.1110.7 (54.8–252.0)
  • aReference group.